Glycated haemoglobin (HbA1c) IVD, reagent
- Device ID
- 210276
- Status
- DREGIY
- Date Registered
- Feb 8, 2025
- Device Type
- In Vitro Diagnostic Device
- Type
- Class A
- Address
- 4231 E. 75th TerraceKansas City, Missouri, United States
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Glycated haemoglobin (HbA1c) IVD, reagent is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 210276. The device is manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech) from United States, classified as In Vitro Diagnostic Device.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.